ATAGI recommendations on use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years

15 November 2022 - On 29 September 2022, the TGA provisionally approved Comirnaty (Pfizer) COVID-19 vaccine for use in children ...

Read more →

TGA provisionally approves Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran) for use in children aged 6 months to less than 5 years

29 September 2022 - On 29 September 2022, the TGA provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran), ...

Read more →

ATAGI recommend the COVID-19 vaccination for some children aged 6 months to under 5 years

26 September 2022 - Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged ...

Read more →

TGA provisionally approves Pfizer's COVID-19 vaccine, Comirnaty (tozinameran), for use as a booster dose in individuals 5 years and older

21 September 2022 - On 20 September 2022, the TGA provisionally approved Pfizer's COVID-19 vaccine, Comirnaty (tozinameran) for use as ...

Read more →

Novavax vaccine for adolescents aged 12-17 years

25 August 2022 - The Australian Technical Advisory Group on Immunisation has evaluated data on immunogenicity, efficacy, safety, and international ...

Read more →

ATAGI recommends COVID-19 vaccine use in some children aged 6 months to 4 years

12 August 2022 - From 5 September 2022, the Australian Technical Advisory Group on Immunisation recommends COVID-19 vaccination for children aged ...

Read more →

TGA commences evaluation of Pfizer's COVID-19 vaccine (Comirnaty) for children aged 6 months to less than 5 years

3 August 2022 - The TGA has commenced evaluation of an application from Pfizer to extend the use of its ...

Read more →

TGA provisionally approves Moderna COVID-19 vaccine (Spikevax) for use in children from 6 months

19 July 2022 - The TGA has provisionally approved a paediatric dose of the Moderna COVID-19 vaccine, Spikevax, for use ...

Read more →

Provisional determination granted to Pfizer in relation to COVID 19 vaccine (Comirnaty) - for use in individuals 6 months up to 5 years

30 June 2022 - On 28 June 2022, the TGA granted a provisional determination to Pfizer Australia in relation to ...

Read more →

TGA commences evaluation of Moderna COVID-19 vaccine (Spikevax) for children aged 6 months to 5 years old

13 May 2022 - The TGA has received, and immediately commenced evaluation of, an application from Moderna to extend the ...

Read more →

ATAGI statement on use of booster doses in adolescents aged 12-15 years

8 April 2022 - A statement from the ATAGI on booster doses in adolescents aged 12-15 years. ...

Read more →

Single dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration

14 March 2022 - Novel paediatric relapse prevention treatment marks a major contribution towards malaria elimination efforts. ...

Read more →

ATAGI recommendations on the use of Spikevax (Moderna) COVID-19 vaccine in children aged 6 to 11 years

23 February 2022 - The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Moderna ...

Read more →

‘Grumpy’ TGA boss unloads over people downplaying COVID’s effect on kids

23 February 2022 - The head of Australia’s medicines regulator has unloaded on those downplaying the effect COVID-19 has on ...

Read more →

Moderna's COVID-19 vaccine (Spikevax) provisionally approved for use in individuals 6 years and older

17 February 2022 - The TGA has provisionally approved the Moderna COVID-19 vaccine, Spikevax, for use in individuals aged 6 ...

Read more →